Physician profile
David Bilstrom
NPI 1790766764
$6,436.33
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,615 · 2020: $1,525 · 2021: $1,066 · 2022: $938 · 2023: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $291.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $2,535.59 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $851.41 | 2019-2022 | |
| Glaxosmithkline, LLC. | $462.89 | 2019-2023 | Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $432.79 | 2020-2023 | Takhzyro |
| Regeneron Healthcare Solutions, INC. | $340.08 | 2019-2023 | Dupixent |
| Csl Behring | $257.23 | 2019-2023 | Hizentra |
| Genentech USA, INC. | $228.14 | 2019-2023 | Xolair |
| Kaleo, INC. | $210.28 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $160.66 | 2019-2023 | |
| Alk-Abello, INC | $144.60 | 2019-2022 | |
| Octapharma USA, INC. | $126.96 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $122.46 | 2020-2022 | |
| Shire North American Group INC | $118.81 | 2019 | |
| Genzyme Corporation | $107.33 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $96.50 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $83.37 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.14 | 2021 | |
| Grifols USA, LLC | $45.91 | 2022 | |
| Aimmune Therapeutics, INC. | $19.88 | 2022 | |
| Abbvie INC. | $16.03 | 2022 | |
| Circassia INC. | $15.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bilstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.